Target intelligence / Profile preview

Chromodomain helicase DNA binding protein 9 (CHD9)

Target
CHD9
Molecular classification
Chromatin remodeler, ATP-dependent DNA helicase, Transcriptional coactivator, Enzyme
01

Overview

Chromodomain helicase DNA binding protein 9 (CHD9) is an ATP-dependent chromatin remodeler and DNA helicase belonging to the CHD subfamily of SF2 helicase proteins. It binds to A/T-rich regulatory DNA regions, acts as a transcriptional coactivator for nuclear receptors (notably PPARA), and plays a role in the remodeling of chromatin structure, thereby regulating gene expression patterns and differentiation programs. Unlike several other CHD family members, CHD9 is not essential for mouse development but shows context- and cell-type-specific gene regulatory roles, influencing transcription, higher-order chromatin organization, and possibly disease states such as cancer and developmental syndromes linked to chromatin regulation[1][2][3][4].

Other names
CHD9KIAA0308KISH2PRIC320AD-013x0008CHD-9CReMMFLJ12178BC022889ATP-dependent helicase CHD9Chromatin-related mesenchymal modulatorChromatin-remodeling factor CHROM1Kismet homolog 2PPAR-alpha-interacting complex protein 320 kDaPeroxisomal proliferator-activated receptor A-interacting complex 320 kDa proteinPPAR{gamma}-interacting cofactor 320 kDaciprofibrate bound protein p240proteinx0008
02

Biological functions

Chromatin remodelingATP-dependent DNA translocationDNA binding and unwindingTranscriptional regulation (coactivator, especially for nuclear receptors such as PPARA)Regulation of cell differentiation, particularly during osteogenesisGlobal gene expression programming
03

Disease associations

Cancer (found in some roles or expression contexts)[1][3]Bone development disorders (osteogenesis, but not essential for development in mice)[1][3]Sacrum chordoma[1]Sifrim-Hitz-Weiss Syndrome[1]Other (as a context-dependent chromatin regulator)
04

Safety considerations

Context-dependent function makes predictability of therapeutic effects challenging[3]Non-essential for development in mice suggests a wide safety window, but effects in human disease remain to be clarified[3]

Beyond the preview

Go deeper on Chromodomain helicase DNA binding protein 9 (CHD9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromodomain helicase DNA binding protein 9 (CHD9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call